SCHEMBL29325831

SCHEMBL29325831

CC(=O)Oc1ccc2c(c1)Oc1cc(C)ccc1N2C(=O)Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.45
P2RX4 Q99571 1/20 0.44
MAOB P27338 2/20 0.40
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HTT P42858 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
KMT2A Q03164 1/20 0.39
CA2 P00918 2/20 0.39
CA5A P35218 2/20 0.39
CA12 O43570 2/20 0.38
CA9 Q16790 2/20 0.38
FLT3 P36888 1/20 0.38
GSTP1 P09211 1/20 0.38
ACHE P22303 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KDM4E B2RXH2 2/20 0.36
GLA P06280 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29326936 0.93 P2RX4 (0.50) LMNAP2RX4MAPTALDH1A1HTT
SCHEMBL31045477 0.93 P2RX4 (0.50) LMNAP2RX4MAPTALDH1A1HTT
SCHEMBL10038462 0.82 MAPT (0.54) LMNAMAPTALDH1A1HTTMEN1
SCHEMBL29325794 0.76 LMNA (0.48) LMNAMAOBMAPTALDH1A1HTT
SCHEMBL23963769 0.71 PTGS2 (0.38) LMNAMAPTALDH1A1HTTMEN1
SCHEMBL30997081 0.71 PTGS2 (0.38) LMNAMAPTALDH1A1HTTMEN1
SCHEMBL23552916 0.69 SMN1; SMN2 (0.49) LMNAP2RX4MAPTALDH1A1MEN1
SCHEMBL9295887 0.69 CA2 (0.33) LMNAMAPTALDH1A1HTTMEN1
SCHEMBL265624 0.68 LMNA (0.67) LMNAMAOBMAPTMEN1KMT2A
SCHEMBL29326329 0.68 L3MBTL1 (0.44) LMNAMAPTALDH1A1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240240226-A1 FLUOROGENIC ASSAY FOR RAPID SCREENING OF BACTERIAL BETA-LACTAMASE ACTIVITY UNIV LELAND STANFORD JUNIOR (US) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240240226-A1 FLUOROGENIC ASSAY FOR RAPID SCREENING OF BACTERIAL BETA-LACTAMASE ACTIVITY CDA, CMBL, CTSF LMNA 854/4885P2RX4 2575/4885MAOB 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.